We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OIBR.C
3601
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$288K ﹤0.01%
261,514
SGRY icon
3602
Surgery Partners
SGRY
$2.01B
$287K ﹤0.01%
38,761
-61,557
-61% -$441K
SVXY icon
3603
ProShares Short VIX Short-Term Futures ETF
SVXY
$228M
$286K ﹤0.01%
10,710
ATRS
3604
DELISTED
Antares Pharma, Inc.
ATRS
$286K ﹤0.01%
85,641
-17,457
-17% -$57.5K
WPX
3605
CALL
DELISTED
WPX Energy, Inc.
WPX
$286K ﹤0.01%
+27,000
New +$285K
SNDL icon
3606
Sundial Growers
SNDL
$320M
$285K ﹤0.01%
+5,950
New +$528K
MTRX icon
3607
Matrix Service
MTRX
$326M
$284K ﹤0.01%
16,596
+1,205
+8% +$22.7K
APEI icon
3608
American Public Education
APEI
$890M
$282K ﹤0.01%
12,621
-950
-7% -$26.1K
INSW icon
3609
International Seaways
INSW
$4.76B
$282K ﹤0.01%
14,622
+487
+3% +$8.61K
UFI icon
3610
UNIFI
UFI
$119M
$281K ﹤0.01%
12,803
-246
-2% -$4.85K
AMAL icon
3611
Amalgamated Financial
AMAL
$1.48B
$280K ﹤0.01%
17,511
+738
+4% +$12K
FIDU icon
3612
Fidelity MSCI Industrials Index ETF
FIDU
$2.3B
$280K ﹤0.01%
+7,021
New +$276K
SFL icon
3613
SFL Corp
SFL
$1.64B
$279K ﹤0.01%
19,844
+6,596
+50% +$88.6K
PGNX
3614
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$279K ﹤0.01%
55,202
+1,282
+2% +$6.39K
ARVN icon
3615
Arvinas
ARVN
$518M
$278K ﹤0.01%
+12,938
New +$317K
TRUE
3616
DELISTED
TrueCar
TRUE
$278K ﹤0.01%
81,810
+7,123
+10% +$31.6K
ALTA
3617
DELISTED
Altabancorp
ALTA
$278K ﹤0.01%
9,835
+1,539
+19% +$43.7K
GOSS icon
3618
Gossamer Bio
GOSS
$82.9M
$277K ﹤0.01%
16,557
+5,010
+43% +$99.6K
DPLO
3619
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$275K ﹤0.01%
56,064
+13,886
+33% +$77.7K
AAOI icon
3620
Applied Optoelectronics
AAOI
$7.57B
$274K ﹤0.01%
24,450
-33
-0.1% -$331
BEDU
3621
DELISTED
Bright Scholar Education Holdings
BEDU
$273K ﹤0.01%
7,059
+1,924
+37% +$72.5K
FNCL icon
3622
Fidelity MSCI Financials Index ETF
FNCL
$2.38B
$273K ﹤0.01%
6,705
-4,680
-41% -$188K
NXTG icon
3623
First Trust Indxx NextG ETF
NXTG
$536M
$273K ﹤0.01%
5,434
TBRG
3624
DELISTED
TruBridge
TBRG
$272K ﹤0.01%
12,048
+4,017
+50% +$97.3K
VKTX icon
3625
Viking Therapeutics
VKTX
$3.7B
$270K ﹤0.01%
39,340
+4,869
+14% +$36.2K

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.